There s a pretty interesting article circulating from CHEST demonstrating increased efficacy of lido in comparison to amiodarone for pulseless VTach/VFib arrest. (Wagner et. al, 2024) We re talking statistically significant odds ratios of 1.15 for achieving ROSC and 1.19 for overall survival, with numbers in the study to provide pretty
The 2024 ACLS guidelines for pulseless VTach recommend amio or lidocaine. Amio is easy to remember for dosing, lidocaine is weight based at
Drug of 2nd choice (vs amiodarone) to terminate VTach and prevent VFib after DC cardioversion Adenosine binds to adenosine receptors in heart tissue
Perform the initial assessment If the patient is in VTach or VFib, this IS a shockable rhythm Apply defibrillator pads (or paddles) and shock the patient with
There s a pretty interesting article circulating from CHEST demonstrating increased efficacy of lido in comparison to amiodarone for pulseless VTach/VFib arrest. (Wagner et. al, 2024) We re talking statistically significant odds ratios of 1.15 for achieving ROSC and 1.19 for overall survival, with numbers in the study to provide pretty
The 2024 ACLS guidelines for pulseless VTach recommend amio or lidocaine. Amio is easy to remember for dosing, lidocaine is weight based at 1-
Perform the initial assessment If the patient is in VTach or VFib, this IS a shockable rhythm Apply defibrillator pads (or paddles) and shock the patient with
Enhance your skills with VTach ACLS training. Learn to manage ventricular tachycardia in critical situations. Enroll now for expert certification!
Non-sustained Vtach may be addressed with medication in some cases, while Vfib and pulseless Vtach require immediate CPR and defibrillation.
Comments